CTMX CytomX Therapeutics, Inc.
Fundamentals / CIK 0001501989 / USDCytomX Therapeutics, Inc. reported $14.03M in revenue and a net loss of $85.42M for the trailing twelve months ended September 30, 2026 (down 71.7% year over year), with a -676.5% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CTMX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$14.03M -71.7% YoY
-
Operating Income TTM-$94.89M -676.5% margin
-
Net Income TTM-$85.42M -609.0% net margin
-
Diluted EPS TTM-$0.39 Split-adjusted
-
Free Cash Flow TTM-$51.00M -363.6% FCF margin
-
Cash & ST Investments Sep 30, 2026$348.0M Total debt: $4.39M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $76.20M | $138.1M | $101.2M | $53.16M | $37.31M | $100.4M | $57.49M | $59.50M | $71.62M | $15.04M |
| Research & Development | $68.73M | $83.38M | $77.68M | $111.6M | $114.2M | $112.9M | $131.6M | $103.9M | $92.28M | $54.76M |
| Total Operating Expenses | $98.56M | $113.1M | $107.7M | $154.5M | $153.4M | $149.0M | $168.4M | $137.4M | $117.9M | $74.63M |
| Operating Income | -$22.36M | $25.00M | -$6.48M | -$101.3M | -$116.0M | -$48.60M | -$110.9M | -$77.87M | -$46.26M | -$59.59M |
| EBITDA | -$21.02M | $26.74M | -$4.34M | -$98.89M | -$113.3M | -$46.06M | -$108.2M | -$75.99M | -$44.61M | -$57.85M |
| Interest Income | $5.21M | $7.14M | $9.84M | $1.68M | $255K | $1.84M | $8.37M | $7.64M | $2.67M | $736K |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $1.69M |
| Income Before Tax | -$17.13M | $32.09M | $3.32M | -$99.32M | -$115.9M | -$46.80M | -$102.7M | -$70.30M | -$43.61M | -$58.92M |
| Income Tax Expense | $238K | $224K | $3.89M | $0 | $0 | -$13.91M | -$427K | $14.30M | -$513K | -$19K |
| Net Income | -$17.37M | $31.87M | -$569K | -$99.32M | -$115.9M | -$32.88M | -$102.2M | -$84.60M | -$43.10M | -$58.90M |
| Basic EPS | -- | -- | -- | -- | -- | -- | -- | -- | -$1.16 | -$1.63 |
| Diluted EPS | -- | -- | -- | -- | -- | -- | -- | -- | -$1.16 | -$1.63 |
| Basic Shares Outstanding | 137.9M | 84.4M | 73.8M | 65.7M | 64.1M | 46.1M | 45.3M | 41.7M | 37.2M | 36.2M |
| Diluted Shares Outstanding | 137.9M | 84.7M | 73.8M | 65.7M | 64.1M | 46.1M | 45.3M | 41.7M | 37.2M | 36.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.69M | $1.42M | $10.26M | $663K | $5.96M | $18.66M | $50.92M | $38.09M |
| Research & Development | $16.48M | $17.60M | $19.24M | $21.23M | $15.30M | $13.32M | $18.87M | $14.79M |
| Total Operating Expenses | $25.19M | $25.20M | $29.93M | $28.59M | $21.73M | $19.94M | $28.30M | $20.41M |
| Operating Income | -$23.50M | -$23.78M | -$19.67M | -$27.93M | -$15.77M | -$1.29M | $22.62M | $17.68M |
| Interest Income | $3.27M | $3.16M | $1.49M | $1.48M | $1.59M | $1.18M | $955K | $1.28M |
| Income Before Tax | -$19.94M | -$20.61M | -$18.19M | -$26.46M | -$14.17M | -$91K | $23.59M | $18.94M |
| Income Tax Expense | $61K | $60K | $59K | $54K | $58K | $63K | $62K | $62K |
| Net Income | -$20.00M | -$20.67M | -$18.25M | -$26.51M | -$14.23M | -$154K | $23.52M | $18.88M |
| Basic Shares Outstanding | 219.1M | 218.9M | 177.3M | -- | 165.0M | 129.1M | 87.1M | -- |
| Diluted Shares Outstanding | 219.1M | 218.9M | 177.3M | -- | 165.0M | 129.1M | 87.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $12.67M | $38.05M | $17.17M | $193.7M | $205.5M | $191.9M | $188.4M | $247.6M | $177.5M | $104.6M |
| Short-Term Investments | $124.4M | $62.57M | $157.3M | $0 | $99.70M | $124.3M | $107.7M | $188.6M | $196.6M | -- |
| Cash & Short-Term Investments | $137.1M | $101.9M | $175.4M | $95.57M | $266.3M | $256.3M | $279.4M | $436.1M | $374.1M | $181.9M |
| Accounts Receivable, Net | $2.01M | $3.10M | $3.43M | $35.99M | $790K | $798K | $13K | $97K | $10.14M | $2.16M |
| Total Current Assets | $143.9M | $107.3M | $182.9M | $237.1M | $310.3M | $324.0M | $303.3M | $445.5M | $388.6M | $188.1M |
| Property, Plant & Equipment, Net | $1.30M | $2.47M | $3.96M | $5.07M | $5.96M | $6.95M | $7.37M | $6.93M | $4.22M | $4.39M |
| Goodwill | $949K | $949K | $949K | $949K | $949K | $949K | $949K | $949K | $949K | $949K |
| Other Non-Current Assets | $31K | $66K | $83K | $27K | $901K | $2.17M | $2.02M | $1.38M | $1.35M | $2.97M |
| Total Non-Current Assets | $7.64M | $13.23M | $18.86M | $23.79M | $29.11M | $34.65M | $37.95M | $11.63M | $9.04M | $10.98M |
| Total Assets | $151.6M | $120.5M | $201.8M | $260.9M | $339.4M | $358.7M | $341.3M | $457.1M | $397.6M | $199.1M |
| Accounts Payable | $1.30M | $1.09M | $1.46M | $2.81M | $2.82M | $3.00M | $4.16M | $5.13M | $4.21M | $6.60M |
| Deferred Revenue (Current) | $26.88M | $67.20M | $132.3M | $121.3M | $40.82M | $74.87M | $51.38M | $52.71M | $40.56M | $20.35M |
| Total Current Liabilities | $46.62M | $85.77M | $155.9M | $152.6M | $77.87M | $100.9M | $85.59M | $97.91M | $61.15M | $35.77M |
| Deferred Revenue (Non-Current) | $1.59M | $26.86M | $80.05M | $180.1M | $243.9M | $186.3M | $178.9M | $225.3M | $264.7M | $83.80M |
| Other Non-Current Liabilities | $4.35M | $4.12M | $3.89M | $0 | -- | -- | $850K | $3.05M | $1.90M | $566K |
| Total Non-Current Liabilities | $5.94M | $35.22M | $93.33M | $194.0M | $262.0M | $207.9M | $204.6M | $228.3M | $266.6M | $84.88M |
| Total Liabilities | $52.56M | $121.0M | $249.2M | $346.6M | $339.9M | $308.9M | $290.2M | $326.2M | $327.7M | $120.6M |
| Total Debt (incl. Leases) | $4.24M | $9.38M | $13.97M | $18.06M | $21.67M | $24.87M | $27.68M | -- | -- | -- |
| Common Stock | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$711.9M | -$691.6M | -$723.4M | -$722.9M | -$623.6M | -$450.1M | -$417.2M | -$315.0M | -$219.5M | -$176.4M |
| Accumulated Other Comp. Income | $111K | $27K | $95K | $10K | -$242K | -$47K | $57K | -$93K | -$94K | -$27K |
| Total Stockholders' Equity | $99.01M | -$456K | -$47.45M | -$85.75M | -$459K | -$7.77M | $51.11M | $130.9M | $69.90M | $78.48M |
| Total Equity | $99.01M | -$456K | -$47.45M | -$85.75M | -$459K | -$7.77M | $51.11M | $130.9M | $69.90M | $78.48M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $33.96M | $17.22M | $28.83M | $12.67M | $34.19M | $49.04M | $47.60M | $38.05M |
| Short-Term Investments | $314.0M | $313.1M | $317.9M | $124.4M | $109.4M | $109.0M | $32.28M | $62.57M |
| Cash & Short-Term Investments | $348.0M | $330.3M | $346.7M | $137.1M | $143.6M | $158.1M | $79.90M | $101.9M |
| Accounts Receivable, Net | $501K | $37.49M | $646K | $2.01M | $1.63M | $1.87M | $1.96M | $3.10M |
| Total Current Assets | $356.0M | $373.2M | $353.1M | $143.9M | $149.2M | $164.6M | $86.63M | $107.3M |
| Property, Plant & Equipment, Net | $2.52M | $1.08M | $1.09M | $1.30M | $1.72M | $1.95M | $2.23M | $2.47M |
| Goodwill | $949K | $949K | $949K | $949K | $949K | $949K | $949K | $949K |
| Other Non-Current Assets | $551K | $31K | $31K | $31K | $51K | $56K | $61K | $66K |
| Total Non-Current Assets | $8.63M | $8.07M | $6.26M | $7.64M | $9.04M | $10.44M | $11.87M | $13.23M |
| Total Assets | $364.7M | $381.2M | $359.4M | $151.6M | $158.3M | $175.1M | $98.50M | $120.5M |
| Accounts Payable | $1.14M | $1.94M | $1.37M | $1.30M | $646K | $227K | $276K | $1.09M |
| Deferred Revenue (Current) | $27.41M | $24.07M | $17.88M | $26.88M | $22.38M | $22.05M | $33.23M | $67.20M |
| Total Current Liabilities | $45.53M | $39.86M | $34.02M | $46.62M | $41.03M | $39.22M | $50.20M | $85.77M |
| Deferred Revenue (Non-Current) | $25.86M | $30.62M | $979K | $1.59M | $5.54M | $10.24M | $16.21M | $26.86M |
| Other Non-Current Liabilities | $4.53M | $4.47M | $4.41M | $4.35M | $4.30M | $4.24M | $4.18M | $4.12M |
| Total Non-Current Liabilities | $34.26M | $39.30M | $5.39M | $5.94M | $9.84M | $15.92M | $23.25M | $35.22M |
| Total Liabilities | $79.79M | $79.16M | $39.41M | $52.56M | $50.87M | $55.15M | $73.45M | $121.0M |
| Total Debt (incl. Leases) | $4.39M | $5.70M | $2.86M | $4.24M | $5.60M | $6.88M | $8.15M | $9.38M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K |
| Retained Earnings | -$770.9M | -$750.9M | -$730.2M | -$711.9M | -$682.4M | -$668.2M | -$668.1M | -$691.6M |
| Accumulated Other Comp. Income | -$315K | -$196K | $102K | $111K | $104K | $33K | -$1.0K | $27K |
| Total Stockholders' Equity | $284.9M | $302.1M | $319.9M | $99.01M | $107.4M | $119.9M | $25.05M | -$456K |
| Total Equity | $284.9M | $302.1M | $319.9M | $99.01M | $107.4M | $119.9M | $25.05M | -$456K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$17.37M | $31.87M | -$569K | -$99.32M | -$115.9M | -$32.88M | -$102.2M | -$84.60M | -$43.10M | -$58.90M |
| Depreciation & Amortization | $1.35M | $1.75M | $2.15M | $2.45M | $2.75M | $2.55M | $2.65M | $1.88M | $1.65M | $1.73M |
| Stock-Based Compensation | $6.30M | $7.67M | $8.56M | $13.12M | $13.17M | $14.79M | $19.10M | $16.88M | $11.29M | $10.10M |
| Change in Receivables | $1.09M | $329K | $32.55M | -$35.20M | $8.0K | -$785K | $84K | $10.04M | -$7.98M | -$1.79M |
| Change in Payables | $221K | -$297K | -$1.43M | $68K | -$139K | -$857K | -$374K | $261K | -$2.44M | $1.76M |
| Operating Cash Flow | -$75.59M | -$86.23M | -$56.03M | -$110.8M | -$119.0M | $5.26M | -$140.5M | -$75.52M | $170.4M | -$2.03M |
| Capital Expenditure | -$220K | -$310K | -$840K | -$1.74M | -$1.61M | -$2.31M | -$3.50M | -$3.79M | -$1.56M | -$2.18M |
| Free Cash Flow | -$75.81M | -$86.54M | -$56.88M | -$112.5M | -$120.6M | $2.95M | -$144.0M | -$79.31M | $168.8M | -$4.21M |
| Purchases of Investments | -- | -- | -- | -- | -$99.90M | -$199.1M | -$175.0M | -$204.6M | -$218.7M | -$121.5M |
| Investing Cash Flow | -$59.74M | $99.70M | -$150.7M | $98.26M | $22.49M | -$18.72M | $79.70M | $5.93M | -$121.3M | $45.86M |
| Common Stock Issued | $109.6M | $6.91M | -- | $0 | $107.7M | $11.29M | $0 | $134.6M | $19.96M | -- |
| Financing Cash Flow | $110.4M | $7.52M | $30.23M | $648K | $110.2M | $16.89M | $1.63M | $139.6M | $23.80M | $996K |
| Net Change in Cash | -$24.89M | $20.99M | -$176.5M | -$11.88M | $13.67M | $3.43M | -$59.15M | $70.03M | $72.90M | $44.82M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$20.00M | -$20.67M | -$18.25M | -$26.51M | -$14.23M | -$154K | $23.52M | $18.88M |
| Stock-Based Compensation | $2.84M | $2.58M | $4.71M | $1.48M | $1.38M | $1.43M | $2.01M | $1.88M |
| Change in Receivables | $36.99M | -$36.85M | $1.37M | -$384K | $240K | $87K | $1.15M | $249K |
| Change in Payables | -$932K | $571K | $67K | $655K | $419K | -$49K | -$804K | -$261K |
| Operating Cash Flow | $16.65M | -$18.07M | -$25.55M | -$23.24M | -$15.55M | -$15.75M | -$21.04M | -$19.91M |
| Capital Expenditure | -$589K | $0 | $0 | -$201K | $127K | -$27K | -$119K | -$80K |
| Free Cash Flow | $16.06M | -$18.07M | -$25.55M | -$23.44M | -$15.42M | -$15.78M | -$21.16M | -$19.99M |
| Investing Cash Flow | -$3.0K | $5.95M | -$192.8M | -$14.42M | $439K | -$76.36M | $30.60M | $15.13M |
| Common Stock Issued | $0 | $56K | $228.4M | $16.26M | $0 | $93.37M | $0 | -- |
| Financing Cash Flow | $94K | $511K | $234.5M | $16.64M | $253K | $93.55M | $0 | $2.25M |
| Net Change in Cash | $16.74M | -$11.60M | $16.16M | -$21.02M | -$14.86M | $1.44M | $9.55M | -$2.52M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -29.3% | 18.1% | -6.4% | -190.6% | -311.0% | -48.4% | -192.9% | -130.9% | -64.6% | -396.1% |
| Net Profit Margin | -22.8% | 23.1% | -0.6% | -186.8% | -310.5% | -32.8% | -177.8% | -142.2% | -60.2% | -391.5% |
| Return on Equity (ROE) | -17.5% | -- | -- | -- | -- | -- | -200.0% | -64.6% | -61.7% | -75.1% |
| Return on Assets (ROA) | -11.5% | 26.4% | -0.3% | -38.1% | -34.1% | -9.2% | -30.0% | -18.5% | -10.8% | -29.6% |
| Current Ratio | 3.09x | 1.25x | 1.17x | 1.55x | 3.98x | 3.21x | 3.54x | 4.55x | 6.36x | 5.26x |
| Quick Ratio | 2.98x | 1.22x | 1.15x | 0.86x | 3.43x | 2.55x | 3.26x | 4.46x | 6.28x | 5.15x |
| Debt to Equity | 0.04x | -- | -- | -- | -- | -- | 0.54x | -- | -- | -- |
| Revenue Growth (YoY) | -44.8% | +36.4% | +90.4% | +42.5% | -62.8% | +74.6% | -3.4% | -16.9% | +376.1% | +95.1% |
| Operating Income Growth (YoY) | -189.5% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -154.5% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -2363.4% | -- | -- | -144.3% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -4189.5% | -- | -- | -147.0% | -- | -- |
| 5Y Revenue / Share Growth | -74.6% | +29.0% | -4.0% | -58.0% | +40.1% | +142.4% | -75.3% | +24.2% | -- | -- |
| 10Y Revenue / Share Growth | -38.4% | -68.1% | +19.3% | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -676.5% | -476.2% | -181.9% | -29.4% | 20.5% | 30.6% | 24.4% | 18.1% |
| Net Profit Margin | -609.0% | -435.2% | -166.4% | -22.8% | 24.7% | 34.0% | 28.2% | 23.1% |
| Return on Equity (ROE) | -30.0% | -26.4% | -18.5% | -17.5% | 26.1% | 40.0% | 166.1% | -- |
| Return on Assets (ROA) | -23.4% | -20.9% | -16.5% | -11.5% | 17.7% | 27.4% | 42.2% | 26.4% |
| Current Ratio | 7.82x | 9.36x | 10.38x | 3.09x | 3.64x | 4.20x | 1.73x | 1.25x |
| Quick Ratio | 7.65x | 9.23x | 10.21x | 2.98x | 3.54x | 4.08x | 1.63x | 1.22x |
| Debt to Equity | 0.02x | 0.02x | 0.01x | 0.04x | 0.05x | 0.06x | 0.33x | -- |
| Revenue Growth (YoY) | -71.7% | -92.4% | -79.9% | -98.3% | -82.2% | -25.7% | +22.8% | +43.2% |
| Operating Income Growth (YoY) | -- | -- | -187.0% | -258.0% | -483.6% | -- | +94.1% | -- |
| Net Income Growth (YoY) | -- | -- | -177.6% | -240.4% | -348.1% | -- | +70.6% | +2155.2% |